rs6879219

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001190787.3(MCIDAS):​c.831C>T​(p.Cys277Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.609 in 1,535,834 control chromosomes in the GnomAD database, including 289,311 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 22654 hom., cov: 33)
Exomes 𝑓: 0.62 ( 266657 hom. )

Consequence

MCIDAS
NM_001190787.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.694

Publications

13 publications found
Variant links:
Genes affected
MCIDAS (HGNC:40050): (multiciliate differentiation and DNA synthesis associated cell cycle protein) This gene encodes a member of the geminin family of proteins. The encoded nuclear protein is required for the generation of multiciliated cells in respiratory epithelium. Mutations in this gene cause a rare mucociliary clearance disorder associated with recurring respiratory infections in human patients, known as reduced generation of multiple motile cilia (RGMC). [provided by RefSeq, Sep 2016]
MCIDAS Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 42
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 5-55220693-G-A is Benign according to our data. Variant chr5-55220693-G-A is described in ClinVar as Benign. ClinVar VariationId is 403074.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.694 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCIDASNM_001190787.3 linkc.831C>T p.Cys277Cys synonymous_variant Exon 7 of 7 ENST00000513312.3 NP_001177716.1 D6RGH6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCIDASENST00000513312.3 linkc.831C>T p.Cys277Cys synonymous_variant Exon 7 of 7 1 NM_001190787.3 ENSP00000426359.1 D6RGH6
MCIDASENST00000513468.5 linkn.*295C>T non_coding_transcript_exon_variant Exon 7 of 7 5 ENSP00000422165.1 I6L8E2
MCIDASENST00000513468.5 linkn.*295C>T 3_prime_UTR_variant Exon 7 of 7 5 ENSP00000422165.1 I6L8E2

Frequencies

GnomAD3 genomes
AF:
0.534
AC:
81089
AN:
151952
Hom.:
22648
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.351
Gnomad AMI
AF:
0.610
Gnomad AMR
AF:
0.544
Gnomad ASJ
AF:
0.680
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.605
Gnomad FIN
AF:
0.529
Gnomad MID
AF:
0.659
Gnomad NFE
AF:
0.634
Gnomad OTH
AF:
0.536
GnomAD2 exomes
AF:
0.583
AC:
78419
AN:
134596
AF XY:
0.592
show subpopulations
Gnomad AFR exome
AF:
0.348
Gnomad AMR exome
AF:
0.540
Gnomad ASJ exome
AF:
0.677
Gnomad EAS exome
AF:
0.462
Gnomad FIN exome
AF:
0.543
Gnomad NFE exome
AF:
0.631
Gnomad OTH exome
AF:
0.589
GnomAD4 exome
AF:
0.618
AC:
854495
AN:
1383764
Hom.:
266657
Cov.:
76
AF XY:
0.619
AC XY:
422943
AN XY:
682828
show subpopulations
African (AFR)
AF:
0.341
AC:
10765
AN:
31594
American (AMR)
AF:
0.548
AC:
19553
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.684
AC:
17216
AN:
25178
East Asian (EAS)
AF:
0.482
AC:
17207
AN:
35732
South Asian (SAS)
AF:
0.617
AC:
48915
AN:
79236
European-Finnish (FIN)
AF:
0.538
AC:
18215
AN:
33888
Middle Eastern (MID)
AF:
0.601
AC:
3420
AN:
5690
European-Non Finnish (NFE)
AF:
0.635
AC:
684588
AN:
1078846
Other (OTH)
AF:
0.598
AC:
34616
AN:
57900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
22455
44910
67364
89819
112274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18332
36664
54996
73328
91660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.533
AC:
81124
AN:
152070
Hom.:
22654
Cov.:
33
AF XY:
0.530
AC XY:
39382
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.350
AC:
14544
AN:
41500
American (AMR)
AF:
0.544
AC:
8325
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.680
AC:
2359
AN:
3470
East Asian (EAS)
AF:
0.475
AC:
2444
AN:
5142
South Asian (SAS)
AF:
0.606
AC:
2927
AN:
4828
European-Finnish (FIN)
AF:
0.529
AC:
5591
AN:
10564
Middle Eastern (MID)
AF:
0.661
AC:
193
AN:
292
European-Non Finnish (NFE)
AF:
0.634
AC:
43049
AN:
67954
Other (OTH)
AF:
0.538
AC:
1137
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1906
3812
5719
7625
9531
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.607
Hom.:
20404
Bravo
AF:
0.523
Asia WGS
AF:
0.512
AC:
1779
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ciliary dyskinesia, primary, 42 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
12
DANN
Benign
0.89
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6879219; hg19: chr5-54516521; COSMIC: COSV72813211; COSMIC: COSV72813211; API